Press Release

CluePoints’ Founder To Present On Risk-Based Monitoring At FDA/AdvaMed Conference

The 10th Annual FDA/ADVAMED Medical Devices and Diagnostics Statistical Issues Conference, taking place on April 26, 2017 to April 27, 2017, brings together leading authorities from FDA, industry, and academia to address statistical topics through two tracks – therapeutic device and diagnostics. Hear directly from FDA and industry experts to better understand the latest statistical trends and issues facing medtech organizations today.

CluePoints’ Founder, Marc Buyse, will talk at a session on using Risk-Based Monitoring as a way to both improve data quality and streamline clinical trial costs. Marc will describe an implementation of Central Statistical Monitoring using software that automatically performs a large number of statistical tests on all available data in multicentre clinical trials, resulting in a high-dimensional matrix of P-values which are summarized in an overall score for each centre, the score is analogous to an average P-value, with the low scores indicating the centres that are statistically most different from all others.

Washington Marriott at Metro Center, 775 12th St NW, Washington, DC 20005


 If you haven’t registered already, we recommend registering soon to avoid disappointment.

See you there!

Meet SPOT: Transforming Site Monitoring Practices with Adaptive Intelligence
A New Era of Automation: Improving Efficiency & Outcomes with Intelligent Medical Coding
Press Release
CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations